Access to medical products is a complex global challenge at the interface between health, economics, politics and development. This one-day symposium organised in collaboration with the Swiss Federal Institute of Intellectual Property and the Federal Office of Public Health focuses on a sub-set of access to medicines challenges, using Hepatitis C virus (HCV) as an extended case study to facilitate discussions and novel thinking.
Expanding national treatment programmes
Moderator: Martina Schwab, Co-head, Global Health Section, Swiss Federal Office of Public Health
Evolving innovation models and implications for access
Moderator: Lucas von Wattenwyl, Senior Advisor, Federal Institute of Intellectual Property